v3.26.1
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2023         $ 91,469
Balance (in shares) at Dec. 31, 2023         4,939,946
Increase (Decrease) in Convertible Preferred Stock          
Exchange preferred stock for pre-funded warrants         $ (4,686)
Exchange preferred stock for pre-funded warrants (shares)         (207,902)
Balance at Jul. 30, 2024         $ 86,783
Balance (in shares) at Jul. 30, 2024         4,732,044
Balance at Dec. 31, 2023 $ 1 $ 1,608 $ (133,649) $ 17 $ (132,023)
Balance (in shares) at Dec. 31, 2023 779,908        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       3 3
Exchange preferred stock for pre-funded warrants   4,332     4,332
Stock option exercises   9     $ 9
Stock option exercises (in shares) 305       0
Stock-based compensation   642     $ 642
Net (loss) income     (21,278)   (21,278)
Balance at Jul. 30, 2024 $ 1 6,591 (154,927) 20 $ (148,315)
Balance (in shares) at Jul. 30, 2024 780,213       786,510
Increase (Decrease) in Stockholders' Deficit          
Issuance of common shares, pre-funded warrants and warrants, net of issuance costs   23,433      
Issuance of common shares, pre-funded warrants and warrants, net of issuance costs (in shares) 3,287,018        
Balance at Jul. 31, 2024 $ 1 89,786 (16,823)   $ 72,964
Balance (in shares) at Jul. 31, 2024 13,387,636        
Financial Designation, Predecessor and Successor [Fixed List]         Successor
Balance at Jul. 30, 2024         $ 86,783
Balance (in shares) at Jul. 30, 2024         4,732,044
Balance at Jul. 30, 2024 $ 1 6,591 (154,927) 20 $ (148,315)
Balance (in shares) at Jul. 30, 2024 780,213       786,510
Increase (Decrease) in Stockholders' Deficit          
Net (loss) income         $ (53,800)
Balance at Dec. 31, 2024 $ 2 90,495 (70,586) 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232
Balance at Jul. 31, 2024 $ 1 89,786 (16,823)   $ 72,964
Balance (in shares) at Jul. 31, 2024 13,387,636        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       1 1
Exercise of pre-funded warrants $ 1 709     710
Exercise of pre-funded warrants (in shares) 663,096        
Issuance of earn-out shares (in shares) 1,147,500        
Net (loss) income     (53,763)   (53,763)
Balance at Dec. 31, 2024 $ 2 90,495 (70,586) 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment     61 (100) $ (39)
Issuance of common shares, pre-funded warrants and warrants, net of issuance costs   16,134     16,134
Issuance of common shares, pre-funded warrants and warrants, net of issuance costs (in shares) 5,798,072        
Exercise of pre-funded warrants (in shares) 1,030,822        
Issuance of Waiver Shares (in shares) 183,333        
Stock-based compensation   1,479     $ 1,479
Issuance of earn-out shares (in shares)         1,147,500
Net (loss) income     (25,084)   $ (25,084)
Balance at Dec. 31, 2025 $ 2 $ 108,108 $ (95,609) $ (99) $ 12,402
Balance (in shares) at Dec. 31, 2025 22,210,459       22,210,459